A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia
NCT00764374 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 412
Last updated 2014-10-29
Summary
To examine the safety and efficacy of Z-338 (YM443) after long-term administration in patients with functional dyspepsia, and also to examine the pattern of long-term administration.
Conditions
- Dyspepsia
- Functional Dyspepsia
Interventions
- DRUG
-
YM443
oral
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Central Contact · Astellas Pharma Inc
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
Countries
- Japan
More Related Trials
-
The Effects of Z-338 in Subjects With and Without Functional Dyspepsia
NCT00298194 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Aolanti Weikang Tablets in Healthy Volunteers
NCT03358485 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia
NCT05199441 ·Status: COMPLETED ·Phase: PHASE4
-
Zhizhu Kuanzhong Capsule for Patients With Functional Dyspepsia-Postprandial Distress Syndrome
NCT04380233 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Functional Dyspepsia With Genuine Regional Rhizoma Atractylodis
NCT03173183 ·Status: UNKNOWN ·Phase: NA
-
International Clinical Study of Zhizhu Kuanzhong Capsule
NCT03825692 ·Status: UNKNOWN ·Phase: PHASE4
-
Primary Care dySpEpsia rikkuNshiTo
NCT06482671 ·Status: RECRUITING ·Phase: PHASE3
-
The Clinical Course and Factors for the Progression of Uninvestigated Dyspepsia to Functional Dyspepsia
NCT05823636 ·Status: RECRUITING
-
Study of Motilitone to Treat Functional Dyspepsia
NCT02365701 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia
NCT03617016 ·Status: COMPLETED ·Phase: PHASE4
-
Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia
NCT04449185 ·Status: UNKNOWN ·Phase: PHASE4
-
Tradipitant for Functional Dyspepsia
NCT05653310 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
The Effect of Multiple Medications on the Incidence of Organic Dyspepsia
NCT05524675 ·Status: UNKNOWN
-
Trial to Reduce Inappropriate Oesophagogastroduodenoscopies for Dyspepsia
NCT03205319 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia
NCT03004118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia
NCT00112203 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy
NCT00742599 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Functional Dyspepsia With Acupuncture
NCT00786214 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Preventive Effect of Chlorhexidine Acetate Gargle for Upper Gastrointestinal Tract Infection After ESD
NCT03492827 ·Status: UNKNOWN ·Phase: NA
-
Application of Simethicone in Esophagogastroscopy
NCT03776916 ·Status: COMPLETED ·Phase: NA
-
The Effect of Rikkunshito on Gastric Accommodation and Nutrient Volume Tolerance in Functional Dyspepsia
NCT03856294 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Prednisolone in the Treatment of Esophageal Stricture After Esophageal Surgery
NCT02703376 ·Status: UNKNOWN ·Phase: PHASE1
-
Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms
NCT07250308 ·Status: RECRUITING
-
The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis
NCT02955134 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia
NCT07016269 ·Status: RECRUITING ·Phase: PHASE4